The cervical cancer diagnosis market is estimated to grow at a CAGR of 6.5% during the forecast period. Cervical cancer occurs when the cervical cells grow at an abnormal rate in the cervix over the period. These abnormal cancer cells spread further deeper into cervical tissue and form a mass, known as a tumor. Sometimes in serious cases, these cells spread to other parts of the body. Squamous cell carcinoma, mixed carcinoma, and adenocarcinoma are the three types of cervical cancer. Among these, squamous cell carcinoma is the most common type of cervical cancer and is followed by adenocarcinoma. A major reason for cervical cancer is an infection due to human papillomavirus (HPV). A cervical cancer diagnosis is conducted to detect any changes in the cells of the cervix that could result in cancer. The screening is carried out for testing pre-cancer and cancer in women. The screening can analyze low-grade changes in cervical cells and can easily be treated to avoid cancer. This diagnosis further helps to determine cancer at early stages and can be cured to ensure quality life.

Top Driver: The Growth in the Aging Female Population with the Rise in Awareness Programs for Cervical Cancer diagnosis

The continuous rise of cancer ‘s impact on Public Health is the major factor that drives the Cervical Cancer diagnosis Market. The market for Cervical Cancer diagnosis is also driven by the growth in the aging female population with the rise in awareness Programs for Cervical Cancer diagnosis. Several approaches taken by many organizations to prevent and control Cervical Cancer is also estimated to fuel the market growth during the forecast period. In addition, advancements in technology in diagnostic tools and screening procedures and surging demand for minimal invasive screening procedures is expected to drive the cervical cancer diagnostic market over the forecast period. Favorable reimbursement policies will propel the demand for cervical screening tests, consecutively positively impacting market size growth.

However, the lack of awareness concerning cervical cancer protection can hinder the growth of the Cervical Cancer diagnosis market.

The Pap Testing System Segment is Anticipated to Witness Growth During the Forecast Period

The global cervical cancer diagnosis market has been segmented into pap testing, cervical biopsies, cystoscopy, and HPV testing based on the type. Pap testing holds the largest market share due to growing awareness about cancer and cancer diagnosis tests stimulating a rise in the number of women performing pap tests. The increasing prevalence of cervical cancer in women aged between 21 to 65 years and early detection of cervical cancer, providing preventive treatment for the disease, will stimulate the cervical cancer diagnostic market. Following Pap testing, the HPC testing market is estimated to witness significant growth during the forecast period due to surging demand for cost effective and technologically advanced diagnostic procedures offering precise results. Based on the age group, the market is segmented into age group between 20 to 40 and age group above 40.

North America Market Estimated to Grow at a Significant Pace

North America holds the largest Cervical Cancer diagnosis market, followed by Europe due to the increasing prevalence rate of cervical cancer, thus increasing the acceptance of cervical cancer diagnosis procedures such as adopting automated liquid-based Pap cytology testing alternative to conventional Pap tests. Emerging countries such as China and India are also estimated to show a high development rate in the Cervical Cancer diagnosis market due to improving access to healthcare facilities and massive investments by pharmaceutical and Biotechnological Companies in research centers.

Players to Focus on Full-body scanner market

The global cervical cancer diagnosis is anticipated to stay fragmented due to the new entrants during the forecast period. Major key players operating in the market include Abbott Laboratories, Hologic Corporation, Qiagen N.V., and Hoffmann-La Roche, Quest Diagnostics, Becton, Dickinson and Company, OncoHealth Corp.

Scope of the Report

By Type

• Pap testing
• Cervical biopsies
• Cystoscopy
• HPV testing

By Age Group

• Age group between 20-40
• Age group above 40

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.